Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
48.11
+0.37 (0.78%)
Apr 30, 2026, 3:00 PM CST

Cathay Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
34,67135,88922,55532,01235,74976,786
Market Cap Growth
17.89%59.12%-29.54%-10.45%-53.44%116.67%
Enterprise Value
29,53730,77922,81831,82333,87871,142
Last Close Price
48.1149.8038.4854.2660.32128.99
PE Ratio
58.6764.0146.1387.3464.61129.11
Forward PE
39.6829.6129.6146.7489.6189.61
PS Ratio
10.5210.897.6315.1414.6532.49
PB Ratio
1.631.681.492.172.385.23
P/TBV Ratio
2.042.122.083.063.527.77
P/OCF Ratio
85.7988.8127.4856.2244.48132.69
EV/Sales Ratio
8.969.347.7115.0513.8830.10
EV/EBITDA Ratio
29.8431.1033.5670.5250.43106.53
EV/EBIT Ratio
43.8145.6562.70192.2383.32142.50
Debt / Equity Ratio
0.020.020.130.120.080.05
Debt / EBITDA Ratio
0.510.512.793.941.681.11
Net Debt / Equity Ratio
-0.41-0.41-0.23-0.24-0.34-0.61
Net Debt / EBITDA Ratio
-8.84-8.84-5.07-8.01-7.69-13.31
Net Debt / FCF Ratio
25.7825.78154.133.611.5210.09
Asset Turnover
0.150.150.160.120.140.17
Inventory Turnover
1.651.651.601.011.171.56
Quick Ratio
4.874.871.991.704.758.14
Current Ratio
5.855.852.532.225.959.36
Return on Equity (ROE)
2.91%2.91%3.18%2.74%4.12%4.84%
Return on Assets (ROA)
1.96%1.96%1.20%0.56%1.49%2.20%
Return on Invested Capital (ROIC)
4.52%4.68%2.76%1.43%4.57%7.95%
Return on Capital Employed (ROCE)
3.10%3.10%2.30%1.10%2.50%3.30%
Earnings Yield
1.62%1.56%2.17%1.15%1.55%0.78%
FCF Yield
-0.98%-0.95%-0.10%-3.13%-9.50%-1.15%
Dividend Yield
0.83%-1.04%0.35%0.30%0.25%
Payout Ratio
55.84%55.84%28.80%37.58%37.39%57.11%
Buyback Yield / Dilution
-17.47%-17.47%-0.05%0.10%0.11%-7.38%
Total Shareholder Return
-16.64%-17.47%0.99%0.45%0.41%-7.13%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.